Enrolling by invitationPhase 2
Long-term safety study of BHV-7000 for hard-to-treat focal epilepsy
Tests whether BHV-7000 is safe over time in adults with hard-to-treat focal epilepsy.
Plain-language title generated from the registry record
Registry title: Long-term Safety and Tolerability of BHV-7000
Key facts
- Where
- Ames, Amherst, Augusta, Aurora, Baltimore, Baton Rouge, Bethesda, Birmingham, Boca Raton, Boise, Boston, Bradenton, Burlington, Canton, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Columbia, Columbus, Covington, Cypress, Dallas, Dayton, El Paso, Elgin, Farmington, Fort Worth, Great Neck, Hackensack, Hawthorne, Hialeah, Homestead, Honolulu, Houston, Jacksonville, Kissimmee, La Jolla, Lancaster, Lexington, Lincoln, Little Rock, Livingston, Long Beach, Los Angeles, Marlboro, McLean, Memphis, Miami, Mission Hills, Mooresville, Murray, Nashville, Neptune City, New Haven, New Hyde Park, New Orleans, New York, Orlando, Palo Alto, Pasadena, Peachtree Corners, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Plano, Plymouth, Port Charlotte, Poway, Richmond, Roanoke, Rochester Hills, Rockledge, Rogers, Roseville, Salt Lake City, San Antonio, Shreveport, Silver Spring, South Dartmouth, Springfield, St Louis, Stony Brook, Tampa, The Bronx, Tucson, Weston, Winston-Salem, Winter Park, and Woodmere, United StatesSee the 115 sites
- Phase
- Phase 2
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT06443463, who can take part
Where in United States
- McFarland ClinicAmes, United StatesNo longer taking part
- Dent Neurosciences Research CenterAmherst, United StatesNo longer taking part
- Augusta UniversityAugusta, United StatesNo longer taking part
- Kaiser PermanenteAurora, United StatesNo longer taking part
- University of Colorado Anschultz Medical CampusAurora, United StatesNo longer taking part
- John Hopkins UniversityBaltimore, United StatesNo longer taking part
- DelRicht ResearchBaton Rouge, United StatesNo longer taking part
- OLOLRMCBaton Rouge, United StatesNo longer taking part
- Mid-Atlantic Epilepsy & Sleep Center, LLCBethesda, United StatesNo longer taking part
- Accel ResearchBirmingham, United StatesNo longer taking part
- EZR Research LLCBoca Raton, United StatesNo longer taking part
- Consultants in Epilepsy & Neurology, PLLCBoise, United StatesNo longer taking part
- Boston Clinical TrialsBoston, United StatesNo longer taking part
- Nova Clinical Research, LLCBradenton, United StatesNo longer taking part
- UVM MCBurlington, United StatesNo longer taking part
- NeuroScience Research CenterCanton, United StatesNo longer taking part
- UNC- Chapel HillChapel Hill, United StatesNo longer taking part
- MUSCCharleston, United StatesNo longer taking part
- OnSite Clinical SolutionsCharlotte, United StatesNo longer taking part
- University of VirginiaCharlottesville, United StatesNo longer taking part
- WR-ClinSearchChattanooga, United StatesNo longer taking part
- Northwestern UniversityChicago, United StatesNo longer taking part
- University of CincinnatiCincinnati, United StatesNo longer taking part
- University of Missouri Health CareColumbia, United StatesNo longer taking part
- OSUColumbus, United StatesNo longer taking part
- Neurocare Of LouisianaCovington, United StatesNo longer taking part
- Clinical Research Solutions LLCCypress, United StatesNo longer taking part
- Horizon Clinical Research GroupCypress, United StatesNo longer taking part
- M3 Wake Research-DallasDallas, United StatesNo longer taking part
- Neurology Consultants of Dallas, PADallas, United StatesNo longer taking part
- Premier HealthDayton, United StatesNo longer taking part
- ANESC ResearchEl Paso, United StatesNo longer taking part
- Revive Research Institute, Inc.Elgin, United StatesNo longer taking part
- UConn HealthFarmington, United StatesNo longer taking part
- Tarrant Neurology ConsultantsFort Worth, United StatesNo longer taking part
- Northwell HealthGreat Neck, United StatesNo longer taking part
- NEREGHackensack, United StatesNo longer taking part
- BCHPHawthorne, United StatesNo longer taking part
- Las Mercedes Medical ResearchHialeah, United StatesNo longer taking part
- Coral Clinic ResearchHomestead, United StatesNo longer taking part
- Hawaii Pacific NeuroscienceHonolulu, United StatesNo longer taking part
- Michael E. DeBakey VA Medical CenterHouston, United StatesNo longer taking part
- UTHealth HoustonHouston, United StatesNo longer taking part
- UTHSCHouston, United StatesNo longer taking part
- University of Florida - JacksonvilleJacksonville, United StatesNo longer taking part
- Dm HealthworksKissimmee, United StatesNo longer taking part
- University of California San DiegoLa Jolla, United StatesNo longer taking part
- Amicis Research CenterLancaster, United StatesNo longer taking part
- Bluegrass Epilepsy ResearchLexington, United StatesNo longer taking part
- Somnos Clinical ResearchLincoln, United StatesNo longer taking part
- Clinical Trials Inc.Little Rock, United StatesNo longer taking part
- Inst of NeurologyLivingston, United StatesNo longer taking part
- MemorialCare Miller Children's & Women's Hospital Long BeachLong Beach, United StatesNo longer taking part
- University of California, Los AngelesLos Angeles, United StatesNo longer taking part
- Tekton ResearchMarlboro, United StatesNo longer taking part
- Medstar Health Research InstituteMcLean, United StatesNo longer taking part
- Le Bonheur Children's HospitalMemphis, United StatesNo longer taking part
- Floridian Research InstituteMiami, United StatesNo longer taking part
- Serenity Research CenterMiami, United StatesNo longer taking part
- University of MiamiMiami, United StatesNo longer taking part
- Y&L Advance Health Care, Inc d/b/a Elite Clinical ResearchMiami, United StatesNo longer taking part
- Tri Valley Neurology Medical Associates, Inc.Mission Hills, United StatesNo longer taking part
- AccellacareMooresville, United StatesNo longer taking part
- Intermountain HealthMurray, United StatesNo longer taking part
- Vanderbilt University Medical CenterNashville, United StatesNo longer taking part
- Jersey Shore Medical CenterNeptune City, United StatesNo longer taking part
- Yale School of Medicine - Yale-New Haven HospitalNew Haven, United StatesNo longer taking part
- Northwell HealthNew Hyde Park, United StatesNo longer taking part
- Delricht ResearchNew Orleans, United StatesNo longer taking part
- University Medical Center New OrleansNew Orleans, United StatesNo longer taking part
- NYUNew York, United StatesNo longer taking part
- NYU Langone HealthNew York, United StatesNo longer taking part
- AdventHealth OrlandoOrlando, United StatesNo longer taking part
- Comprehensive Neurology ClinicOrlando, United StatesNo longer taking part
- Research Institute of OrlandoOrlando, United StatesNo longer taking part
- Stanford UniversityPalo Alto, United StatesNo longer taking part
- Profound Research LLCPasadena, United StatesNo longer taking part
- Accelerated Clinical Trials, LLCPeachtree Corners, United StatesNo longer taking part
- Panhandle Research & Medical ClinicPensacola, United StatesNo longer taking part
- Onyx Clinical TrialsPeoria, United StatesNo longer taking part
- Thomas Jefferson UniversityPhiladelphia, United StatesNo longer taking part
- University of PennsylvaniaPhiladelphia, United StatesNo longer taking part
- ARENSIA Exploratory MedicinePhoenix, United StatesNo longer taking part
- Barrow Neurological InstitutePhoenix, United StatesNo longer taking part
- University of Arizona/Banner University Medical Center PhoenixPhoenix, United StatesNo longer taking part
- Xenoscience Inc.Phoenix, United StatesNo longer taking part
- AHNPittsburgh, United StatesNo longer taking part
- UPMCPittsburgh, United StatesNo longer taking part
- Stryde ResearchPlano, United StatesNo longer taking part
- SRI InternationalPlymouth, United StatesNo longer taking part
- Medsol Clinical Research CenterPort Charlotte, United StatesNo longer taking part
- Profound Research LLCPoway, United StatesNo longer taking part
- Henrico Doctors Neurology Associates, LLCRichmond, United StatesNo longer taking part
- Carilion ClinicRoanoke, United StatesNo longer taking part
- Revive Research Institute, Inc.Rochester Hills, United StatesNo longer taking part
- Knight NeurologyRockledge, United StatesNo longer taking part
- WRNRogers, United StatesNo longer taking part
- Minnesota Epilepsy Group, P.A.Roseville, United StatesNo longer taking part
- University of UtahSalt Lake City, United StatesNo longer taking part
- Road Runner Research, LtdSan Antonio, United StatesNo longer taking part
- UT Health San AntonioSan Antonio, United StatesNo longer taking part
- LSU Health ShreveportShreveport, United StatesNo longer taking part
- JavaraSilver Spring, United StatesNo longer taking part
- Boston Neuro ResearchSouth Dartmouth, United StatesNo longer taking part
- Oregon Neurology AssociatesSpringfield, United StatesNo longer taking part
- Washington University School of MedicineSt Louis, United StatesNo longer taking part
- Stony Brook MedicineStony Brook, United StatesNo longer taking part
- PENSTampa, United StatesNo longer taking part
- Santos Research CenterTampa, United StatesNo longer taking part
- Montefiore Medical CenterThe Bronx, United StatesNo longer taking part
- Center for NeurosciencesTucson, United StatesNo longer taking part
- Encore Medical Research of Weston, LLCWeston, United StatesNo longer taking part
- Wake Forest BaptistWinston-Salem, United StatesNo longer taking part
- Pediatrix Medical Group of FloridaWinter Park, United StatesNo longer taking part
- Five Towns Neuroscience ResearchWoodmere, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Biohaven Therapeutics Ltd.
- Trial code
- NCT06443463EU 2023-508813-18-00
- Record updated
- 1 May 2026
- Original description
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsyRead full original descriptionShow less
A Phase 2, Global, Multicenter, Long-term Safety Study Designed to Assess the Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
Inclusion: Subjects who completed the double-blind phase (DBP) of prior parent study, BHV7000-302 or BHV7000-303; (FOCBP) Females of Child Bearing Potential must have a negative urine pregnancy test at the Baseline/Day 0 visit.
Exclusion: Any condition, such as an ongoing AE with/without sequelae, or is poorly tolerating IP in the double-blind phase of the parent study, that would interfere with the subject's ability to comply with study instructions, place the subject at unacceptable risk, and/or confound the interpretation of safety or efficacy data from the study, as judged by the Investigator; Any medical condition, based on the judgement of the Investigator, that would confound the ability to adequately assess safety and efficacy outcome measures.